Cited by 33Forensic Toxicology and Drug AnalysisPoisoning and overdose treatmentsSubstance Abuse Treatment and Outcomes

New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic

Open access
Lo Faro, Alfredo, Berardinelli, Diletta, Cassano, Tommaso, Dendramis, Gregory, Montanari, Eva, Montana, Angelo, Berretta, Paolo, Zaami, Simona +2 more·2023·Biology

Abstract

In January 2020, the World Health Organization (WHO) issued a Public Health Emergency of International Concern, declaring the COVID-19 outbreak a pandemic in March 2020. Stringent measures decreased consumption of some drugs, moving the illicit market to alternative substances, such as New Psychoactive Substances (NPS). A systematic literature search was performed, using scientific databases such as PubMed, Scopus, Web of Science and institutional and government websites, to identify reported intoxications and fatalities from NPS during the COVID-19 pandemic. The search terms were: COVID-19, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2, coronavirus disease 2019, intox*, fatal*, new psychoactive substance, novel psychoactive substance, smart drugs, new psychoactive substance, novel synthetic opioid, synthetic opioid, synthetic cathinone, bath salts, legal highs, nitazene, bath salt, legal high, synthetic cannabinoid, phenethylamine, phencyclidine, piperazine, novel benzodiazepine, benzodiazepine analogue, designer benzodiazepines, tryptamine and psychostimulant. From January 2020 to March 2022, 215 NPS exposures were reported in Europe, UK, Japan and USA. Single NPS class intoxications accounted for 25, while mixed NPS class intoxications represented only 3 cases. A total of 130 NPS single class fatalities and 56 fatalities involving mixed NPS classes were published during the pandemic. Synthetic opioids were the NPS class most abused, followed by synthetic cathinones and synthetic cannabinoids. Notably, designer benzodiazepines were frequently found in combination with fentalogues. Considering the stress to communities and healthcare systems generated by the pandemic, NPS-related information may be underestimated. However, we could not define the exact impacts of COVID-19 on processing of toxicological data, autopsy and death investigations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biology12020273

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [2]European Monitoring Centre for Drugs and Drug Addiction Results from an EMCDDA Trendspotter Study Impact of COVID-19 on Drug Markets, Use, Harms and Drug Services in the Community and Prisons I Legal Notice European Monitoring Centre for Drugs and Drug Addiction Lisbon, Portugal 2021 10.2810/222454 · DOI
  2. [4]Winstock A. Davies E. Gilchrist G. Zhuparris A. Ferris J. Maier L.B.M. GDS Special Edition on COVID-19 Global Interim Report 02/06/2020 Available online: https://www.globaldrugsurvey.com/wp-content/themes/globaldrugsurvey/assets/GDS_COVID-19-GLOBAL_Interim_Report-2020.pdf (accessed on 15 March 2022)
  3. [45]Feisthauer E. Farrugia A. Ameline A. Gheddar L. Arbouche N. Raul J.S. Kintz P. Interest in testing for 4-ANPP in biological matrices as a precursor of exposure to fentanyl or to a fentanyl derivative Toxicol. Anal. Clin. 2021 33 338 342 10.1016/j.toxac.2021.09.001 · DOI

Cited by

Sorted by citations

Authors
Lo Faro, A., Berardinelli, D., Cassano, T., Dendramis, G., Montanari, E., Montana, A., Berretta, P., Zaami, S., Busardò, F., & Huestis, M.
Affiliations
  • Department of Excellence Biomedical Sciences and Public Health, Marche Polytechnic University, 60121 Ancona, Italy
  • Marche Polytechnic University (IT)
  • University of Foggia (IT)
  • Department of Cardiology, ARNAS Ospedale Civico di Cristina Benfratelli, 90127 Palermo, Italy
  • Istituto Superiore di Sanità (IT)
  • Sapienza University of Rome (IT)
  • Thomas Jefferson University (US)
Corresponding author
Zaami, Simona
Venue
Biology
Publisher
MDPI AG
Published
2023-02-08
Volume
12
Issue
2
Pages
273
ISSN
2079-7737 (ISSN-L)
OpenAlex
W4319754802
Cited by
33
References
73
Citations by year
2026: 3 · 2025: 11 · 2024: 15 · 2023: 4
FWCI
1.28
Type
journal article
Language
en
Open access
Locations
  • Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
  • The Medicine Forum (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion, cc-by)
Funders
  • National Early Warning System on Drugs (SNAP)
  • Implementation of the identification and study of the effects of NPS
  • Italian Department of Antidrug policies
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
new psychoactive substances, COVID-19 pandemic, drug poisoning, drug-related deaths, synthetic opioids, synthetic cathinones, synthetic cannabinoids, designer benzodiazepines, fentanyl analogs, illicit drug markets, toxicological data

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review